Page 10 - Mick Readey News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Investegate |GSK PLC Announcements | GSK PLC: IDMC recommends gepotidacin early efficacy stop

Investegate announcements from GSK PLC, IDMC recommends gepotidacin early efficacy stop

United kingdomUnited statesCity ofUnited kingdom generalDan smithKathleen quinnJosh williamsJeff mclaughlinMick readeyLyndsay meyerTim foleyJames dodwellChris corsicoNick stoneUs department of healthHuman services

Investegate |GSK PLC Announcements | GSK PLC: 3rd Quarter Results

Investegate |GSK PLC Announcements | GSK PLC: 3rd Quarter Results
investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesCity ofUnited kingdom generalFluarix flulavalsalesEmma walmsleyKathleen quinnInfanrix pediarixfavourableJeff mclaughlinShingrixin europeMick readeyTim foleyJames dodwellAdvair seretideJoshua williamsNick stone

Investegate |GSK PLC Announcements | GSK PLC: GSK announces FDA meeting outcome on daprodustat

Investegate announcements from GSK PLC, GSK announces FDA meeting outcome on daprodustat

United kingdomUnited statesUnited kingdom generalCity ofDan smithKathleen quinnJosh williamsJeff mclaughlinMick readeyLyndsay meyerTim foleyJames dodwellChris corsicoNick stoneCompany annual report on formJapan ministry of health

ViiV Healthcare presents positive proof-of-concept findings for N6LS, an investigational, broadly neutralising antibody (bNAb) offering a potential new approach for the treatment of HIV

Data from the BANNER study show antiviral efficacy, safety, and tolerability of N6LS, supporting its continued study in phase IIb ViiV Healthcare, the global specialist HIV company majority owned

Glasgow cityUnited kingdomNorth carolinaUnited statesUnited kingdom generalBuenos airesDistrito federalCity ofKimberly smithMadeleine breckonKathleen quinnJosh williamsJeff mclaughlinMick readeyAudrey abernathyLyndsay meyer

Investegate |GSK PLC Announcements | GSK PLC: US FDA ODAC review of Zejula Phase III NOVA trial

Investegate announcements from GSK PLC, US FDA ODAC review of Zejula Phase III NOVA trial

United kingdomUnited statesCity ofUnited kingdom generalHesham abdullahDan smithKathleen quinnJosh williamsJeff mclaughlinMick readeyLyndsay meyerTim foleyJames dodwellNick stoneCompany annual report on formOncologic drugs advisory committee